COVID-19 Implications for I-O Patient Management

 View Only
last person joined: one year ago 

This discussion board is devoted to conversations directly relevant to clinical care. Example topics include:
• Trends in demographics
• Trends in clinical presentation
• Issues regarding diagnostic testing
• Patient management issues/insights
• Observations on emerging natural history/patterns in clinical complications
• Difficult cases
Back to discussions
Expand all | Collapse all

Immune checkpoint inhibitors and COVID-19

  • 1.  Immune checkpoint inhibitors and COVID-19

    Posted 04-28-2020 18:46
      |   view attached

    Dear all,

    Please find attached a statement about use of immune checkpoint inhibitor therapy in context of COVID-19 pandemic for IO field's consideration.

    Best regards

    Rajat



    ------------------------------
    Rajat Mohindra MD
    Senior Group Medical Director, Product Development Safety
    Roche
    Basel
    ------------------------------

    Attachment(s)

    docx
    ICIs and COVID-19_statement_April 2020.docx   26 KB 1 version